Avastin(R) (bevacizumab) Now Approved For Use In Combination With Docetaxel For The F

[News]

More patients with metastatic breast cancer could benefit from Avastin (bevacizumab) as a result of a broader label announced by the European Commission that allows bevacizumab to be combined with either docetaxel or paclitaxel chemotherapy1.

More... (http://www.medicalnewstoday.com/articles/159368.php)